Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)
  4. Fast Track Articles
  5. Fast Track Article
image of Associations of Chronic Hepatitis B and Nonalcoholic Fatty Liver Diseases with New-Onset Metabolic Syndrome in Military Personnel before Midlife: A Cohort Study
file format pdf download PDF

Abstract

Background

Hepatic inflammation, , Nonalcoholic Fatty Liver Diseases (NAFLD) and the severe form of steatohepatitis (NASH), has been associated with a higher risk of MetS in the general population.

Aims

This study aimed to investigate the associations of chronic hepatitis B (CHB) and fatty liver diseases with the incidence of metabolic syndrome (MetS) in young adults, which have not been verified before.

Objective

The associations between NAFLD, NASH, and CHB and the incidence of new-onset MetS remain inconclusive in young adults.

Methods

This cohort study included 2,614 military personnel aged 18-39 years who were free of baseline MetS in 2014 and were followed for the incidence of MetS in each annual health examination until the end of 2020. CHB was defined by the presence of the hepatitis B surface antigen with an established diagnosis history. NAFLD and NASH were defined by the ultrasound finding with an elevated alanine transaminase (27–53.9 and ≥54 U/L in men and 15–29.9 and ≥30 U/L in women, respectively). MetS was defined based on the International Diabetes Federation criteria. Multivariable Cox regression analysis was used to determine the associations between hepatitis and incident MetS.

Results

During a mean follow-up of 6.0 years, 582 new-onset MetS cases occurred (22.3%). NAFLD and NASH were associated with a greater risk of new-onset MetS (hazard ratios (HRs) and 95% confidence intervals: 1.47 (1.21-1.79) and 1.66 (1.16-2.39), respectively), while no association for CHB was found (HR: 1.31 (0.88-1.96)).

Conclusion

This study found that NAFLD and NASH, while not CHB, were independent risk factors of new-onset MetS with adjustments for potential covariates, , physical activity and fitness in young adults.

© 2025 The Author(s). Published by Bentham Science Publishers
© 2025 The Author(s). Published by Bentham Science Publishers. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode.
Loading

Article metrics loading...

/content/journals/emiddt/10.2174/0118715303323078241022050619
2025-01-09
2025-06-01

  • From This Site

    /content/journals/emiddt/10.2174/0118715303323078241022050619
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 2002 106 25 3143 3421 10.1161/circ.106.25.3143 12485966
    [Google Scholar]
  2. Tsai K.Z. Huang W.C. Sui X. Lavie C.J. Lin G.M. Moderate or greater daily coffee consumption is associated with lower incidence of metabolic syndrome in Taiwanese militaries: Results from the CHIEF cohort study. Front. Nutr. 2023 10 1321916 10.3389/fnut.2023.1321916 38156279
    [Google Scholar]
  3. Ranasinghe P. Mathangasinghe Y. Jayawardena R. Hills A.P. Misra A. Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: A systematic review. BMC Public Health 2017 17 1 101 10.1186/s12889‑017‑4041‑1 28109251
    [Google Scholar]
  4. Saklayen M.G. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 2018 20 2 12 10.1007/s11906‑018‑0812‑z 29480368
    [Google Scholar]
  5. Tylutka A. Morawin B. Walas Ł. Michałek M. Gwara A. Zembron-Lacny A. Assessment of metabolic syndrome predictors in relation to inflammation and visceral fat tissue in older adults. Sci. Rep. 2023 13 1 89 10.1038/s41598‑022‑27269‑6 36596839
    [Google Scholar]
  6. Wang C.C. Cheng P.N. Kao J.H. Systematic review: Chronic viral hepatitis and metabolic derangement. Aliment. Pharmacol. Ther. 2020 51 2 216 230 10.1111/apt.15575 31746482
    [Google Scholar]
  7. Siegel A.B. Zhu A.X. Metabolic syndrome and hepatocellular carcinoma. Cancer 2009 115 24 5651 5661 10.1002/cncr.24687 19834957
    [Google Scholar]
  8. Wong V.W.S. Wong G.L.H. Chu W.C.W. Chim A.M.L. Ong A. Yeung D.K.W. Yiu K.K.L. Chu S.H.T. Chan H.Y. Woo J. Chan F.K.L. Chan H.L.Y. Hepatitis B virus infection and fatty liver in the general population. J. Hepatol. 2012 56 3 533 540 10.1016/j.jhep.2011.09.013 22027575
    [Google Scholar]
  9. Katoonizadeh A. Ghoroghi S. Sharafkhah M. Khoshnia M. Mirzaei S. Shayanrad A. Poustchi H. Malekzadeh R. Chronic hepatitis B infection is not associated with increased risk of vascular mortality while having an association with metabolic syndrome. J. Med. Virol. 2016 88 7 1230 1237 10.1002/jmv.24466 26742819
    [Google Scholar]
  10. Wang C.C. Tseng T.C. Kao J.H. Hepatitis B virus infection and metabolic syndrome: Fact or fiction? J. Gastroenterol. Hepatol. 2015 30 1 14 20 10.1111/jgh.12700 25092429
    [Google Scholar]
  11. Li W.C. Lee Y.Y. Chen I.C. Sun C. Chiu F.H. Chuang C.H. Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age. Liver Int. 2013 33 8 1194 1202 10.1111/liv.12224 23782533
    [Google Scholar]
  12. Chung T.H. Kim M.C. Kim C.S. Association between hepatitis B surface antigen seropositivity and metabolic syndrome. Korean J. Fam. Med. 2014 35 2 81 89 10.4082/kjfm.2014.35.2.81 24724003
    [Google Scholar]
  13. Jan C-F. Chen C-J. Chiu Y-H. Chen L-S. Wu H-M. Huang C-C. Yen M-F. Chen T.H-H. A population-based study investigating the association between metabolic syndrome and Hepatitis B/C infection (Keelung Community-based Integrated Screening Study No. 10). Int. J. Obes. 2006 30 5 794 799 10.1038/sj.ijo.0803204 16404404
    [Google Scholar]
  14. Lin G.M. Li Y.H. Lee C.J. Shiang J.C. Lin K.H. Chen K.W. Chen Y.J. Wu C.F. Lin B.S. Yu Y.S. Lin F. Su F.Y. Wang C.H. Rationale and design of the cardiorespiratory fitness and hospitalization events in armed forces study in Eastern Taiwan. World J. Cardiol. 2016 8 8 464 471 10.4330/wjc.v8.i8.464 27621774
    [Google Scholar]
  15. Lin J.W. Tsai K.Z. Chen K.W. Su F.Y. Li Y.H. Lin Y.P. Han C.L. Lin F. Lin Y.K. Hsieh C.B. Lin G.M. Sex-Specific association between serum uric acid and elevated alanine aminotransferase in a military cohort: The chief study. Endocr. Metab. Immune Disord. Drug Targets 2019 19 3 333 340 10.2174/1871530319666181129163802 30499423
    [Google Scholar]
  16. Tsai K.Z. Lin J-W. Lin F. Su F-Y. Li Y-H. Lin Y-P. Lin Y-K. Han C-L. Hsieh C-B. Lin G-M. Association of betel nut chewing with exercise performance in a military male cohort: The CHIEF study. J. R. Army Med. Corps 2018 164 6 399 404 10.1136/jramc‑2017‑000899 30012664
    [Google Scholar]
  17. Wang S.H. Chung P.S. Lin Y.P. Tsai K.Z. Lin S.C. Fan C.H. Lin Y.K. Lin G.M. Metabolically healthy obesity and physical fitness in military males in the CHIEF study. Sci. Rep. 2021 11 1 9088 10.1038/s41598‑021‑88728‑0 33907258
    [Google Scholar]
  18. Chen Y.J. Chen K.W. Shih Y.L. Su F.Y. Lin Y.P. Meng F.C. Lin F. Yu Y.S. Han C.L. Wang C.H. Lin J.W. Hsieh T.Y. Li Y.H. Lin G.M. Chronic hepatitis B, nonalcoholic steatohepatitis and physical fitness of military males: CHIEF study. World J. Gastroenterol. 2017 23 25 4587 4594 10.3748/wjg.v23.i25.4587 28740347
    [Google Scholar]
  19. Suh S.Y. Choi S.E. Ahn H.Y. Yang H.M. Kim Y.I. Sung N.J. The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey. Metabolism 2009 58 12 1731 1736 10.1016/j.metabol.2009.05.028 19604521
    [Google Scholar]
  20. World Health Organization Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. Geneva, Switzerland World Health Organization 2000 11234459
    [Google Scholar]
  21. Tsai K.Z. Huang R.Y. Cheng W.C. Han C.L. Huang W.C. Sui X. Lavie C.J. Lin G.M. Association between dental calculus and hypertension phenotypes in highly fit adults: CHIEF oral health study. Am. J. Hypertens. 2023 36 2 102 108 10.1093/ajh/hpac119 36270011
    [Google Scholar]
  22. Lin G-M. Chou Y-T. Chen K-W. Liu P-Y. Tsai K-Z. Lin Y.P. Hepatic and systemic inflammation for left ventricular mass in physically fit adults: Chief heart study. Endocr. Metab. Immune Disord. Drug Targets 2023 23 7 977 983 10.2174/1871530323666230119145010 36658706
    [Google Scholar]
  23. Lin G.M. Liu P.Y. Tsai K.Z. Lin Y.K. Huang W.C. Lavie C. Cardiorespiratory fitness and carotid intima–media thickness in physically active young adults: Chief atherosclerosis study. J. Clin. Med. 2022 11 13 3653 10.3390/jcm11133653 35806938
    [Google Scholar]
  24. Farrell G.C. Chitturi S. Lau G.K.K. Sollano J.D. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: Executive summary. J. Gastroenterol. Hepatol. 2007 22 6 775 777 10.1111/j.1440‑1746.2007.05002.x 17565629
    [Google Scholar]
  25. Habibullah M. Jemmieh K. Ouda A. Haider M.Z. Malki M.I. Elzouki A.N. Metabolic-associated fatty liver disease: A selective review of pathogenesis, diagnostic approaches, and therapeutic strategies. Front. Med. (Lausanne) 2024 11 1291501 10.3389/fmed.2024.1291501 38323033
    [Google Scholar]
  26. Passos E. Ascensão A. Martins M.J. Magalhães J. Endoplasmic reticulum stress response in non-alcoholic steatohepatitis: The possible role of physical exercise. Metabolism 2015 64 7 780 792 10.1016/j.metabol.2015.02.003 25838034
    [Google Scholar]
  27. Ashraf N.U. Sheikh T.A. Endoplasmic reticulum stress and Oxidative stress in the pathogenesis of Non-alcoholic fatty liver disease. Free Radic. Res. 2015 49 12 1405 1418 10.3109/10715762.2015.1078461 26223319
    [Google Scholar]
  28. Angelico F. Alcantara-Payawal D. Rani R.A. Mustafa N. Thongtang N. Chaiteerakij R. Review and expert opinion on MAFLD, oxidative stress and multifunctional management. Drugs Context 2023 2024 13 38264403
    [Google Scholar]
  29. Polyzos S.A. Toulis K.A. Goulis D.G. Zavos C. Kountouras J. Serum total adiponectin in nonalcoholic fatty liver disease: A systematic review and meta-analysis. Metabolism 2011 60 3 313 326 10.1016/j.metabol.2010.09.003 21040935
    [Google Scholar]
  30. Jinjuvadia R. Liangpunsakul S. Association between metabolic syndrome and its individual components with viral hepatitis B. Am. J. Med. Sci. 2014 347 1 23 27 10.1097/MAJ.0b013e31828b25a5 23514672
    [Google Scholar]
  31. Li Y. Zhao Y. Wu J. Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis. PLoS One 2017 12 5 e0177713 10.1371/journal.pone.0177713 28505202
    [Google Scholar]
  32. Zhou Y. Cui Y. Deng H. Yu J. Association between hepatitis B virus infection and metabolic syndrome: A retrospective cohort study in Shanghai, China. BMC Public Health 2014 14 1 516 10.1186/1471‑2458‑14‑516 24885963
    [Google Scholar]
  33. Masaki T. Chiba S. Tatsukawa H. Yasuda T. Noguchi H. Seike M. Yoshimatsu H. Adiponectin protects LPS-induced liver injury through modulation of TNF-? in KK-Ay obese mice. Hepatology 2004 40 1 177 184 10.1002/hep.20282 15239101
    [Google Scholar]
  34. Razi B. Alizadeh S. Omidkhoda A. Imani D. Rezaei R. Association of chronic hepatitis B infection with metabolic syndrome and its components: Meta-analysis of observational studies. Diabetes Metab. Syndr. 2017 11 Suppl. 2 S939 S947 10.1016/j.dsx.2017.07.020 28701286
    [Google Scholar]
  35. Yen S-L. Chiu T-Y. Lin Y-C. Lee Y-C. Lee L-T. Huang K-C. Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. Int. J. Obes. 2008 32 3 474 480 10.1038/sj.ijo.0803753 17955029
    [Google Scholar]
  36. Cusi K. Isaacs S. Barb D. Basu R. Caprio S. Garvey W.T. Kashyap S. Mechanick J.I. Mouzaki M. Nadolsky K. Rinella M.E. Vos M.B. Younossi Z. American association of clinical endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and endocrinology clinical settings. Endocr. Pract. 2022 28 5 528 562 10.1016/j.eprac.2022.03.010 35569886
    [Google Scholar]
/content/journals/emiddt/10.2174/0118715303323078241022050619
Loading
Associations of Chronic Hepatitis B and Nonalcoholic Fatty Liver Diseases with New-Onset Metabolic Syndrome in Military Personnel before Midlife: A Cohort Study
Bentham Science Publishers ; https://doi.org/10.2174/0118715303323078241022050619
/content/journals/emiddt/10.2174/0118715303323078241022050619
/content/journals/emiddt/10.2174/0118715303323078241022050619
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: metabolic syndrome ; military health ; nonalcoholic fatty liver disease ; nonalcoholic steatohepatitis ; young adults ; Chronic hepatitis B

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test